New EWMA Council members
With this initiative EWMA will investigate the barriers and possibilities of advanced therapies in the next generation wound management.
The primary deliverable is a document including an introduction to the available technologies based on cellular therapies, tissue engineering and tissue substitutes, which are all technologies associated with the clinical discipline of regenerative medicine. The document also describes new treatments based on physical therapies and the potential of sensors and software.
The EWMA document Advanced Therapies in Wound Management was published as an online supplement to the Journal of Wound Care in May 2018.
Please note that you will be redirected to the EWMA Knowledge Centre site where you are kindly asked to create a profile to log in and download the document.
Overall aim of the document:
The objectives of the document are to:
Due to the general lack of scientific documentation of many of these emerging therapies, the document will be based on the available literature as well as expert opinions. It will include an evaluation of the potentials for future use in clinical practice and call for research in recommended areas.
Editor: Alberto Piaggesi (Italy, University of Pisa, EWMA Executive Committee member)
Co-editor: Severin Läuchli (Switzerland, University Hospital, Zürich, EWMA President)
Franco Bassetto (Italy, University of Padova)
Alexandra P. Marques (Portugal, 3B’s Research Group)
Bijan Najafi (US, Baylor College of Medicine)
Thomas Biedermann (Switzerland, Kinderspital Zürich)
Giuseppe Turchetti (Italy, Scula Superiore Sant'Anna
Diane Seimetz (Germany, Biopharma Excellence)
Publiced by the Journal of Wound Care in May 2018, with official launch at the EWMA 2018 Conference in Krakow, Poland.
This project is supported by an unrestricted grant from: